ENA Respiratory Secures Two US Patents for COPD Therapy
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
Read MoreResearchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.
Read MoreResearchers at Adelaide University developed a lipid-polymer vehicle that improves drug bioavailability and reduces systemic toxicity in preclinical models of lung cancer.
Read MoreThis article will provide 8 recommendations for effective patient education regarding inhaled medications used in treating/preventing asthma symptoms and flare-ups.
Read MoreA study of Medicare Advantage beneficiaries with COPD shows that pharmacist-led telephone education significantly reduces errors in medication delivery.
Read MoreReducing dampness through insulation and ventilation improvements can lead to measurable reductions in asthma treatments, particularly for pediatric populations.
Read MoreMaison, Porush & Theil — inventors of the pressure metered dose inhaler (pMDI) — will be posthumously inducted into the National Inventors Hall of Fame in May 2026.
Read MorePulling Flovent from the market in 2024 resulted in GSK profits and harm to pediatric asthma patients, according to a US Senate investigation reported by CNN.
Read MoreAffordability and education are preventing COPD patients from remaining adherent to their prescribed pharmacologies.
Read MoreUpdated VA/DOD asthma guidelines prioritize inhaled steroids while rejecting air filtration devices.
Read MoreA Phase 1 clinical trial of Qnovia’s RespiRx handheld inhalable nicotine replacement therapy (NRT) revealed cigarette-comparable nicotine delivery with favorable safety profile.
Read MoreThe SperaChamber features an anti-static design and a one-way valve to help ensure patients receive their full medication dose.
Read MoreThe Dynarex Resp-O2 50 PSI compressor provides continuous delivery of aerosolized medication and humidified air for use in clinical and home healthcare settings.
Read MoreTrudell Medical International’s AeroChamber2go Spacer, a 2-in-1 spacer and protective inhaler, has earned a Good Design Award.
Read MoreAmneal Pharma’s new albuterol sulfate inhalation aerosol offers a generic equivalent for Teva’s ProAir HFA.
Read MoreAmneal Pharma’s new Beclomethasone Dipropionate HFA Inhalation Aerosol offers a generic equivalent for Teva’s Qvar.
Read MoreEnsifentrine provided consistent, clinically significant benefits across multiple patient reported outcomes in non-exacerbating COPD patients.
Read MoreInhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, UCLA researchers say.
Read MoreRT’s 2025 Product Focus provides a detailed look at 68 of the newest medical devices, including 33 exclusive products not available in the print edition.
Read MoreDigital inhalers can monitor changes in how much air is inhaled, duration of inhalation, to detect potential COPD exacerbations.
Read MoreA look at the latest aerosol delivery products from Aerogen, Alliance Tech Medical, Dynarex, Monaghan Medical, and Sunset Healthcare.
Read MoreUnderstanding how to help asthma patients perform self-monitoring and self-management in the home is the key to provide quality, effective support.
Read MoreThe phase 1 trial evaluates the nicotine inhaler as a smoking cessation therapy, aiming to improve nicotine delivery and support smokers in quitting.
Read MoreFinancial hardship remains a deterrent to medication adherence for 1-in-6 adults with asthma, according to research published in Thorax.
Read More